
❄️Lyophilized powder (not reconstituted)
Size:
Discount per Quantity
| Quantity | Discount | Price per Unit |
|---|---|---|
| 5 - 10 | 10% | €40.49 |
| 11 - 20 | 15% | €38.24 |
| 21+ | 20% | €35.99 |
Rigorous third-party testing
Every batch of our research chemicals and peptides undergoes independent third-party laboratory testing for purity and identity.
Total: €44.99
Ipamorelin is supplied as a catalogued research material in 5 mg and 10 mg.
Ipamorelin is a defined synthetic pentapeptide containing non-proteinogenic and D-configured residues. Registry values apply to the neutral structure shown; they must not be transferred to an unspecified acetate, trifluoroacetate or other salt.
| Property | Value |
|---|---|
| Name and synonyms | NNC 26-0161, Ipamorelin free base |
| Material category | Growth Hormone Secretagogue |
| Sequence | H-Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| Molecular formula | C38H49N9O5 |
| Average molecular mass | 711.87 g/mol |
| CAS Registry Number | 170851-70-4 |
| PubChem CID | CID 9831759 |
| Structural features | Synthetic pentapeptide ghrelin mimetic containing non-proteinogenic amino acids (Aib, D-2-Nal, D-Phe) and a C-terminal amide. |
| Appearance | White to off-white lyophilised powder |
| Solubility | Soluble in bacteriostatic or sterile water. |
| Physical form | Catalogue vial; exact salt/counter-ion and excipients are batch-specific and must be verified in the CoA and SDS. |
Registry values apply only to the specific molecular entity, sequence, termini and material form. Batch records take precedence over family-level literature identifiers.
Ipamorelin is a potent and selective growth hormone releasing peptide (GHRP) and ghrelin receptor agonist. It stimulates GH release with minimal effect on cortisol or prolactin levels.
Ipamorelin has been studied in receptor and preclinical systems as a synthetic ligand associated with the growth-hormone secretagogue receptor pathway. Assay response depends on receptor expression, species, matrix and the exact chemical form.
The available literature is predominantly mechanistic and preclinical and does not authenticate this batch. Findings for endogenous acyl-ghrelin or other secretagogue ligands cannot be transferred to ipamorelin.
| Aspect | This catalogue material | Comparator |
|---|---|---|
| Identity | Synthetic amidated pentapeptide with Aib, D-2-Nal and D-Phe | Acyl-ghrelin: endogenous 28-residue peptide bearing an essential octanoyl modification |
| Structural distinction | Compact peptidomimetic structure with non-natural stereochemistry and C-terminal amidation | Ghrelin is a longer natural peptide whose acylation state is a separate critical identity attribute |
| Analytical implication | Confirm stereochemical sequence, intact mass, purity, terminal amide and salt or counter-ion | Receptor-pathway overlap does not establish structural identity or analytical interchangeability |
Quality information is batch- and presentation-specific. Use only the report linked to the exact size and lot. A report listed for another size, lot or similarly named material must not be treated as evidence for this product.
Chromatographic area purity, identity, net peptide or analyte content, water or counter-ion content, sterility, endotoxin and elemental impurities are different measurements. One result does not establish the others. Only tests supported by a visible, matching report should be regarded as available.
Store and handle only under the conditions stated on the product label, batch CoA and SDS. Keep the container secured, correctly identified and protected from contamination. Do not infer storage, solvent compatibility or stability from a related compound.
Laboratory preparation, analytical-method selection, risk assessment, personal protective equipment and waste disposal should follow the applicable SDS and the institution's approved procedures.
| Research-use notice | This material is supplied exclusively for laboratory research by qualified professionals and is not intended for human or veterinary use. Purchasers are responsible for compliance with applicable local requirements. |
Only when the exact sequence or structure, termini, conjugation, salt or counter-ion and hydration state match. The batch CoA and SDS govern; a related-compound identifier must not be substituted.
It is method- and report-specific. For example, an HPLC area percentage is not automatically the same as identity, net content, sterility, endotoxin status or absence of elemental impurities.
Follow the exact label, batch CoA and SDS together with the institution's risk assessment. Use only storage and stability information linked to the exact material form and batch.